Professor Arthur Burnett described the results as excellent

A new treatment for erectile dysfunction has been produced by Timm Medical Technologies which could help men who only respond partially to the impotence meds Viagra, Cialis and Levitra.  The product which is called ErecAid is described by its manufacturer as a "supplemental first line treatment for erectile dysfunction" has been tested in clinical trials by the Johns Hopkins School of Medicine and seen to produce positive results.

Plethora Solutions Holdings who own Timm Medical Technologies organised four individual research locations which looked at 69 men between the ages of 36 and 82 who suffered from erectile dysfunction of different severity and who had also not responded adequately to the use of Viagra, Cialis or Levitra. For the trial the men were told to continue to use the impotence drugs but at the same time were also told to use the ErecAid product.

The ErecAid is a vacuum erection device which its manufacturers claim is one of the best on the market. These vacuum erection devices have been around for many years but have slipped out of the limelight following the arrival of PDE-5 inhibitors like Viagra, Cialis and Levitra.The collection of data for the study utilised three different methods. Firstly the well established International Index of Erectile Function method was used, secondly the Sexual Encounter Profiles SEP-2 and SEP-3 were used and lastly the Global Patient Assessment Scale.

The men who took part in the study using the ErecAid noted significant improvements in the International Index of Erectile Function scores from nine to 17.6. Added to this out of 34 men who had been unable to get satisfactory erections to have sexual intercourse at the start of the study, 27 of them were able to have sex. Also 42 of the men who said that they had very little response from Viagra, Cialis or Levitra said that with the use of the ErecAid they had "moderate or great" improvements by the end of the four week study.

Professor Arthur Burnett who led the study at the Johns Hopkins School of Medicine described the results as excellent and said that he would encourage doctors who treat men for erectile dysfunction to consider the use of this new device alongside the existing treatments Viagra, Cialis and Levitra.